R2R Biofluidics EU project recently received the Austrian Fast Forward Award 2018

Proceeds provide OMEICOS with the financial runway to conduct the Phase II Study PROMISE-AF and continue expansion into ophthalmology through US subsidiary

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins announced today that it has completed a cell line development project for one of Zymeworks Inc.’s bispecific antibody program which exceeded…

Forbion invests €12.5m from its recently launched Forbion IV fund

OMEICOS is pioneering the development of stable analogs of omega-3 fatty acid metabolites for Cardiovascular Disease and Ophthalmology

Forbion, a leading European life science…

Eyeluminati from India chosen out of 60 applications from 19 countries

10th World Health Summit has kicked off in Berlin/Germany

German Federal Minister of Health Jens Spahn announces long-term support for the core mandate of WHO at the World Health Summit Opening Ceremony in Berlin

World leaders from politics, science, industry and civil society will meet from October 14-16 to discuss the best ways to reach the United Nation health targets

German diagnostics company sphingotec GmbH has closed a €20m growth equity financing round led by international healthcare specialist investors HBM and Wellington Partners.

The European Commission awards the EU-OPENSCREEN consortium the coveted status of European Research Infrastructure Consortium (ERIC). The consortium brings together the infrastructure of 20 research institutes from currently seven European countries.…